DNOW Inc. shareholders have until Oct 2 to act in securities class action lawsuit
News provided byDNOW Inc · 1 min read
NEW YORK, Sept. 4, 2026 /CourierPR/ -- DNOW Inc. shareholders have a critical deadline to consider as a securities class action lawsuit has been filed by The Rosen Law Firm on their behalf. The firm is urging investors who purchased DNOW Inc. common stock as of the August 5, 2025 record date and were thus entitled to vote at the September 9, 2025 special meeting to take action by October 2, 2026, as this date marks the lead plaintiff deadline.
According to The Rosen Law Firm, the lawsuit alleges that DNOW Inc. and its officers made false or misleading statements, or failed to disclose material information regarding the company’s business and operations. Specifically, the firm claims that DNOW understated the challenges associated with its merger with MRC Global Inc. due to issues with MRC Global’s new enterprise resources planning system. The lawsuit further asserts that these omissions and misstatements led to materially false and misleading statements about the company’s prospects and operations.
The Rosen Law Firm has a proven track record of success, having achieved the largest settlement ever in a securities class action against a Chinese company. Additionally, the firm has been ranked number one by ISS Securities Class Action Services for the highest number of securities class action settlements in 2017 and has recovered billions of dollars for investors. In 2019, the firm secured over $438 million for investors, and founding partner Laurence Rosen was named a Titan of the Plaintiffs' Bar by law360 in 2020.
While a class has not yet been certified, investors are encouraged to act promptly to potentially recover damages. If a lead plaintiff is not appointed, the court will select one. Investors may also choose to remain as absent class members and not take any action at this time.
For further updates, investors can follow The Rosen Law Firm on LinkedIn, Twitter, or Facebook. The firm emphasizes that prior results do not guarantee similar outcomes in future cases.